Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Pilot study to begin for new breast cancer blood test
April 19th, 2005
Biomarker Technologies, LLC, announced plans to begin a pilot study of the test in the United States beginning in April 2005. The company is conducting the pilot study to verify its prior results and make final preparations for U.S. Food & Drug Administration (FDA) clinical studies. The study will be a retrospective blind test with samples from healthy participants, those with untreated breast cancer, as well as those from a select group of other cancer conditions in order to demonstrate the differentiation capabilities of the test. In initial studies involving more than 250 subjects, the BT Test successfully identified non-treated breast cancer in...
Source: Cancer Weekly (2005-04-19)
|
